Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection

Coronavirus disease 2019 (COVID-19) has been a pandemic for the past two years. Predicting patient prognosis is critical. Although immune checkpoints (ICs) were shown to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, quantitative studies of ICs in clinical pra...

Full description

Bibliographic Details
Main Authors: Nuri Lee, Seri Jeong, Kibum Jeon, Min-Jeong Park, Wonkeun Song
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.903419/full
_version_ 1811215379183173632
author Nuri Lee
Seri Jeong
Kibum Jeon
Min-Jeong Park
Wonkeun Song
author_facet Nuri Lee
Seri Jeong
Kibum Jeon
Min-Jeong Park
Wonkeun Song
author_sort Nuri Lee
collection DOAJ
description Coronavirus disease 2019 (COVID-19) has been a pandemic for the past two years. Predicting patient prognosis is critical. Although immune checkpoints (ICs) were shown to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, quantitative studies of ICs in clinical practice are limited. In this study, various soluble ICs (sICs) and cytokine levels in patients with SARS-CoV-2 infection at different time points were compared between survivors and deaths; we also examined whether sICs are useful for predicting prognosis. sICs and cytokines were measured in serum samples from 38 patients diagnosed with COVID-19 in the first and second week post-diagnosis. All assays were performed by bead-based multiplexed immunoassay system using Luminex Bio-Plex 200 system. The correlation of sICs and cytokines with laboratory markers was evaluated, and the levels of sICs in survivors were compared with those in deaths. Among the sICs, the second-week levels of soluble cluster of differentiation (sCD27, p = 0.012), sCD40 (p< 0.001), cytotoxic T-lymphocyte-associated protein 4 (sCTLA-4, p< 0.001), herpes virus entry mediator (sHVEM, p = 0.026), and T-cell immunoglobulin and mucin-domain containing-3 (sTIM-3, p = 0.002) were significantly higher in deaths than in survivors. The levels of nine cytokines assessed in the second week of deaths were significantly higher than those in survivors. The sICs sCD27, sCD40, sCTLA-4, and sTIM-3 and cytokines chemokine CC motif ligand 2 (CCL2), GM-CSF, IL-10, and IL-8 showed significant positive correlations with the levels of C-reactive protein (CRP) and procalcitonin and were negatively correlated with the absolute lymphocyte count and platelet values. Increased levels of sICs including sCD27, sCD40, sCTLA-4, and sTIM-3 and cytokines were significant factors for poor prognosis. sICs, together with cytokines and inflammatory markers, may be useful as prognostic stratification markers in SARS-CoV-2-infected patients.
first_indexed 2024-04-12T06:20:48Z
format Article
id doaj.art-af0604fde63b4fdd9518656f0a1c5caa
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-12T06:20:48Z
publishDate 2022-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-af0604fde63b4fdd9518656f0a1c5caa2022-12-22T03:44:19ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-08-011310.3389/fimmu.2022.903419903419Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infectionNuri Lee0Seri Jeong1Kibum Jeon2Min-Jeong Park3Wonkeun Song4Department of Laboratory Medicine, Hallym University College of Medicine, Seoul, South KoreaDepartment of Laboratory Medicine, Hallym University College of Medicine, Seoul, South KoreaDepartment of Laboratory Medicine, Hallym University College of Medicine, Hangang Sacred Heart Hospital, Seoul, South KoreaDepartment of Laboratory Medicine, Hallym University College of Medicine, Seoul, South KoreaDepartment of Laboratory Medicine, Hallym University College of Medicine, Seoul, South KoreaCoronavirus disease 2019 (COVID-19) has been a pandemic for the past two years. Predicting patient prognosis is critical. Although immune checkpoints (ICs) were shown to be involved in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, quantitative studies of ICs in clinical practice are limited. In this study, various soluble ICs (sICs) and cytokine levels in patients with SARS-CoV-2 infection at different time points were compared between survivors and deaths; we also examined whether sICs are useful for predicting prognosis. sICs and cytokines were measured in serum samples from 38 patients diagnosed with COVID-19 in the first and second week post-diagnosis. All assays were performed by bead-based multiplexed immunoassay system using Luminex Bio-Plex 200 system. The correlation of sICs and cytokines with laboratory markers was evaluated, and the levels of sICs in survivors were compared with those in deaths. Among the sICs, the second-week levels of soluble cluster of differentiation (sCD27, p = 0.012), sCD40 (p< 0.001), cytotoxic T-lymphocyte-associated protein 4 (sCTLA-4, p< 0.001), herpes virus entry mediator (sHVEM, p = 0.026), and T-cell immunoglobulin and mucin-domain containing-3 (sTIM-3, p = 0.002) were significantly higher in deaths than in survivors. The levels of nine cytokines assessed in the second week of deaths were significantly higher than those in survivors. The sICs sCD27, sCD40, sCTLA-4, and sTIM-3 and cytokines chemokine CC motif ligand 2 (CCL2), GM-CSF, IL-10, and IL-8 showed significant positive correlations with the levels of C-reactive protein (CRP) and procalcitonin and were negatively correlated with the absolute lymphocyte count and platelet values. Increased levels of sICs including sCD27, sCD40, sCTLA-4, and sTIM-3 and cytokines were significant factors for poor prognosis. sICs, together with cytokines and inflammatory markers, may be useful as prognostic stratification markers in SARS-CoV-2-infected patients.https://www.frontiersin.org/articles/10.3389/fimmu.2022.903419/fullimmune checkpointCOVID-19cytokine release syndromeSARS-CoV-2prognosis
spellingShingle Nuri Lee
Seri Jeong
Kibum Jeon
Min-Jeong Park
Wonkeun Song
Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
Frontiers in Immunology
immune checkpoint
COVID-19
cytokine release syndrome
SARS-CoV-2
prognosis
title Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
title_full Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
title_fullStr Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
title_full_unstemmed Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
title_short Prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with SARS-CoV-2 infection
title_sort prognostic impacts of soluble immune checkpoint regulators and cytokines in patients with sars cov 2 infection
topic immune checkpoint
COVID-19
cytokine release syndrome
SARS-CoV-2
prognosis
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.903419/full
work_keys_str_mv AT nurilee prognosticimpactsofsolubleimmunecheckpointregulatorsandcytokinesinpatientswithsarscov2infection
AT serijeong prognosticimpactsofsolubleimmunecheckpointregulatorsandcytokinesinpatientswithsarscov2infection
AT kibumjeon prognosticimpactsofsolubleimmunecheckpointregulatorsandcytokinesinpatientswithsarscov2infection
AT minjeongpark prognosticimpactsofsolubleimmunecheckpointregulatorsandcytokinesinpatientswithsarscov2infection
AT wonkeunsong prognosticimpactsofsolubleimmunecheckpointregulatorsandcytokinesinpatientswithsarscov2infection